Drug Discontinuation

HPS Pharmacies wish to give notice that Pfizer Australia has discontinued papaverine 30mg ampoules as follows:

DBL Papaverine Ampoules
Papaverine 30mg/1mL
ARTG 16258

DBL™ Papaverine 120mg/10mL ampoules are currently still available. International brands of papaverine ampoules may be accessed via the Special Access Scheme (SAS), if necessary. Please note that SAS alternatives are subject to a longer lead-time and different pricing as they must be sourced internationally.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Pfizer Australia on 1800 629 921 or your pharmacist at HPS Pharmacies.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates